Quick Takeaways
- Jorey Chernett filed SCHEDULE 13G for AEON Biopharma, Inc. Common (AEON).
- Disclosed ownership: 9.9%.
- Date of event: 27 May 2025.
Jorey Chernett - 27 May 2025 SCHEDULE 13G Report for AEON Biopharma, Inc. Common (AEON)
- Filing Manager
- Jorey Chernett
- Reporting Manager
- Chernett Jorey
- Security
- AEON Biopharma, Inc. Common
- Symbol
- AEON
- Shares outstanding
- 11,398,990 shares
- Disclosed Ownership
- 1,128,500 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 30 May 2025, 12:10:37 UTC
- Date of event
- 27 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Jorey Chernett disclosed 9.9% ownership in AEON Biopharma, Inc. Common (AEON) on 27 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 May 2025, 12:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Chernett Jorey | 9.9% | 1,128,500 | 1,128,500 | 0 | /s/Jorey Chernett | Individual |